Bioorganic and Medicinal Chemistry Letters p. 533 - 538 (1999)
Update date:2022-08-03
Topics:
Nomura, Masahiro
Kinoshita, Susumu
Satoh, Hiroya
Maeda, Toshio
Murakami, Koji
Tsunoda, Masaki
Miyachi, Hiroyuki
Awano, Katsuya
A series of 3-[(2,4-dioxothiazolidin-5-yl)methyl]benzamide derivatives was prepared as part of a search for antidiabetic agents. A structure- activity relationship study of these compounds led to the identification of 5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[4- (trifluoromethyl)phenyl]methyl]benzamide (KRP-297) as a candidate drug for the treatment of diabetes mellitus.
View MoreHangzhou LINGEBA Technology Co., Ltd.
Contact:+0086-571-87389059
Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
Zhuzhou Farshine Chemical Industry Co., Ltd
Contact:0086-731-28482786
Address:No. 1,Shui Xian Road, He Tang Dictrict,Hunan-412000,China
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Hangzhou yi lu biont technology Co., LTD
Contact:+86-571-88152630
Address:Hangzhoushi HuafengRoad Yicheng3Building1001room.
Contact:0572-2722882
Address:1201,F3,xinghuibandao,
Doi:10.1002/anie.201701691
(2017)Doi:10.1016/S0040-4020(98)00102-1
(1998)Doi:10.1016/S0957-4166(98)00040-8
(1998)Doi:10.1021/ja01018a027
(1968)Doi:10.1016/j.jorganchem.2015.07.017
(2015)Doi:10.1002/cmdc.201700243
(2017)
